These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6399604

  • 1. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L, Arteaga A, Velasco N, Pellegrino MR, Foradori A, López G, Acosta AM.
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract] [Full Text] [Related]

  • 2. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L, Korányi L, Tamás G.
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [C-peptide levels in secondary sulfonylurea resistant diabetics].
    Balázsi I, Takács J, Hargitai G.
    Orv Hetil; 1993 Dec 26; 134(52):2859-62. PubMed ID: 8272351
    [Abstract] [Full Text] [Related]

  • 5. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B.
    Diabetes; 2007 Aug 26; 56(8):2110-5. PubMed ID: 17473222
    [Abstract] [Full Text] [Related]

  • 6. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB, Pyke DA, Watkins PJ, Binder C, Faber OK.
    N Z Med J; 1979 Apr 25; 89(634):304-6. PubMed ID: 377156
    [Abstract] [Full Text] [Related]

  • 7. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR, Groop L.
    Ann Clin Res; 1984 Apr 25; 16(2):118-27. PubMed ID: 6380385
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD, Iwamoto Y, Matsuda A, Kuzuya T.
    Endocrinol Jpn; 1987 Aug 25; 34(4):561-7. PubMed ID: 3315640
    [Abstract] [Full Text] [Related]

  • 10. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y, Kondo K, Hasegawa H, Oiso Y.
    Diabetes Res; 1994 Aug 25; 25(3):129-37. PubMed ID: 7671552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C, Thamprasit A, Leelawattana R, Soonthornpun S, Setasuban W.
    J Med Assoc Thai; 2001 Dec 25; 84(12):1754-62. PubMed ID: 11999824
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of C-peptide determination].
    Meier C, Ladewig A, Keller U, Berger W.
    Praxis (Bern 1994); 1997 Aug 20; 86(34):1289-95. PubMed ID: 9381016
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul 20; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ.
    Dan Med Bull; 1992 Oct 12; 39(5):438-52. PubMed ID: 1424818
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the beta cell response by C-peptide measurement in parents of children with type I diabetes.
    Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Nanditha R, Vijay V, Hitman GA.
    J Assoc Physicians India; 2003 Sep 12; 51():927-8. PubMed ID: 14710988
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.